Webinar objectives:

1. Understand the role that historical and ongoing marginalization play in research participation

2. Discuss how research findings in homogeneous populations are not generalizable to all children

3. Describe research approaches that can improve diversity and inclusion in pediatric clinical trials

Meet the speaker!
Dr Tamorah Lewis is a physician scientist, Division Head for Clinical Pharmacology and Toxicology at SickKids. In this role, Dr Lewis helps advance the hospital-wide vision for Precision Child Health and collaborates with multiple clinical Divisions for pharmacology research. Dr Lewis also continues to provide clinical care in the level IV Neonatal ICU at SickKids. The goals of Dr Lewis’ research program are to bring precision therapeutics to the NICU population. Dr Lewis’ interests include PBPK and population pharmacokinetic and pharmacodynamic investigations in neonates and children, pertaining to both drugs in common use and drugs under development. Her research focuses on the intersection between ontogeny and pharmacogenetic effects on pharmacology of drugs in infants and neonates. In addition to her clinical and research roles, Dr Lewis is a dedicated advocate for Health Equity. Through publications and talks, she educates about the need for increased diversity in the biomedical workforce and the importance of diversity and equity in clinical research and clinical care.